At a Senate Drug Hearing in April 2016, you, Senator Jeff Sessions (R – AL), president-elect Donald Trump’s nominee for Attorney General, said “I believe the Department of Justice needs to be clearer” about marijuana legalization.
“Speechless” is an understandable word to explain how many folks feel at the time of the writing of this article, only 72 hours after Donald Trump became the President-elect of the United States. Whether you supported Trump or Clinton, the Democrats or Republicans, no one can deny that the election night upset on November 8th…
Recently, the American Nurses Association (ANA) came out with a statement declaring their acknowledgement of cannabis as medically beneficial, and asking the federal government to reschedule cannabis for the purpose of furthering medical studies.
As hard as it may be to turn away from the spectacle that occurs on the nightly news, there is a lot more to this voting season than the high drama of the presidential election; it is also a busy time for medical marijuana reform. And while much of the media in this regard is…
By now most of us probably know that research and anecdata (referenced in our last blog as anecdotal evidence based on personal observations and experiences) strongly suggests that cannabis has the ability to heal cancer.
Cannabis has been gaining momentum as a viable and safe medical treatment over the last several years. More and more people are seeking cannabis to treat a variety of ailments.
There’s a common, disparaging word predictably thrown out by critics and skeptics to describe positive experience with cannabis to self-treat serious illnesses and their symptoms: “anecdata.”
It’s difficult to avoid the reality that, no matter your state or how you may personally feel about it, the pharmacy door has opened for cannabis, something that, in all likelihood, won’t be just a guest in the field of medicine.
Last week, the United States Drug Enforcement Agency (DEA) decided to maintain marijuana’s status as a Schedule 1 Drug under the Controlled Substance Act. By definition, substances on Schedule 1 have been determined by the U.S. Food and Drug Administration (FDA) as having “no medical use whatsoever” and are also deemed to have a “high potential for abuse.” At the same time, the DEA’s decision came with a relaxation of some of the rules regarding medical cannabis research
Last weekend, three young people lost their lives from what appear to be drug overdoses while attending a rave in Fontana, CA. Sadly, this is becoming more and more prevalent, with the LA Times reporting that “Before this weekend, there have been at least 24 confirmed drug-related deaths nationwide since 2006 among people who went to raves…”.